JENNIFER UMBARGER: Open Payments
NPI 1447724935 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,639 in 149 payments from 20 companies in 2025. Trend: 2023 $2,440 · 2024 $2,528 · 2025 $4,639
Food & beverage: $2,971Travel & lodging: $1,568Education: $100
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 13 | $1,931 |
| AstraZeneca Pharmaceuticals LP | 31 | $633 |
| JAZZ PHARMACEUTICALS INC. | 13 | $452 |
| GlaxoSmithKline, LLC. | 24 | $336 |
| Actelion Pharmaceuticals US, Inc. | 11 | $285 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $214 |
| Electromed, Inc. | 11 | $96 |
| Merck Sharp & Dohme LLC | 4 | $86 |
| Axsome Therapeutics, Inc. | 4 | $76 |
| Regeneron Healthcare Solutions, Inc. | 3 | $75 |
Products named: INSPIRE, XYWAV, TEZSPIRE, OPSUMIT, NUCALA, BREZTRI, DUPIXENT, TRELEGY ELLIPTA.
Industry payments across AL — which companies pay providers there.
